Leaflet ARKETIS 30mg tablets


Indicated for: depression; anxiety disorders

Route of administration: oral

Substance: paroxetine (selective serotonin reuptake inhibitor)

ATC: N06AB05 (Nervous system | Antidepressants | Selective serotonin reuptake inhibitors)

Precautions:
Driving impairment
Driving impairment

This medicine may affect your ability to drive or use machines.

Dizziness / vertigo
Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Major drug interactions
Major drug interactions

This medicine may have important interactions with other medicines.

Breastfeeding warning
Breastfeeding warning

Use during breastfeeding only on medical advice.

Pregnancy warning
Pregnancy warning

Use during pregnancy only on medical advice.

Suicidal ideation / mental changes
Suicidal ideation / mental changes

Seek medical help if suicidal thoughts or major behavior changes occur.

Withdrawal / do not stop abruptly
Withdrawal / do not stop abruptly

Do not stop treatment abruptly without medical advice.

Drowsiness / sedation
Drowsiness / sedation

This medicine may cause drowsiness or reduced alertness.

Paroxetine is an antidepressant medication used for the treatment of major depression, generalized anxiety disorder, obsessive-compulsive disorder, and other similar conditions. It belongs to the class of selective serotonin reuptake inhibitors (SSRIs) and works by increasing serotonin levels in the brain.

The medication is taken orally, usually once daily, and should be used as directed by your doctor. It is important not to abruptly discontinue treatment to avoid withdrawal symptoms.

Side effects may include nausea, drowsiness, dizziness, dry mouth, or decreased libido. In rare cases, severe reactions such as serotonin syndrome or worsening of depressive symptoms may occur.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as bipolar disorder or epilepsy, to ensure the safe use of paroxetine.

General data about ARKETIS 30mg

  • Substance: paroxetine
  • Date of last drug list: 01-07-2013
  • Commercial code: W43395002
  • Concentration: 30mg
  • Pharmaceutical form: tablets
  • Quantity: 20
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: FARMACEUTISCH ANALYTISCH LAB. DUIVEN BV - OLANDA
  • Holder: MEDOCHEMIE LTD. - CIPRU
  • Number: 9668/2017/02
  • Shelf life: 3 years

Pharmaceutical forms available for paroxetine

Concentrations available for paroxetine

  • 10mg
  • 20mg
  • 30mg
  • 40mg